SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-003743
Filing Date
2015-08-12
Accepted
2015-08-12 16:05:46
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT opxa_10q.htm 10-Q 664169
2 CERTIFICATION opxa_ex311.htm EX-31.1 15696
3 CERTIFICATION opxa_ex312.htm EX-31.2 15313
4 CERTIFICATION opxa_ex321.htm EX-32.1 7570
5 CERTIFICATION opxa_ex322.htm EX-32.2 7067
12 logo.jpg GRAPHIC 2618
  Complete submission text file 0001354488-15-003743.txt   1799347

Data Files

Seq Description Document Type Size
6 opxa-20150630.xml EX-101.INS 138844
7 opxa-20150630.xsd EX-101.SCH 23658
8 opxa-20150630_cal.xml EX-101.CAL 28615
9 opxa-20150630_def.xml EX-101.DEF 36160
10 opxa-20150630_lab.xml EX-101.LAB 179690
11 opxa-20150630_pre.xml EX-101.PRE 109145
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 151047063
SIC: 2834 Pharmaceutical Preparations